
Protein Linked to Melanoma Growth May Suppress the Body’s Natural Anti-Tumor Immune Response
Jun 17, 2026 - 00:04:33
Radio and PodcastLive Radio & Podcasts
BUFFALO, NY – June 15, 2026 – A new paper was in Volume 17 of Oncotarget on June 5, 2026, titled “A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepC...
HPV Vaccine Shows Safety but Uncertain Benefit in Preventing Head & Neck Cancer Recurrence is an episode from Oncotarget by Oncotarget Podcast. BUFFALO, NY – June 15, 2026 – A new paper was in Volume 17 of Oncotarget on June 5, 2026, titled...
This episode belongs to Oncotarget.
Use the player on this page to stream the episode online.
Published Jun 15, 2026, 00:04:36 long, audio available.